NL7306462A - - Google Patents

Info

Publication number
NL7306462A
NL7306462A NL7306462A NL7306462A NL7306462A NL 7306462 A NL7306462 A NL 7306462A NL 7306462 A NL7306462 A NL 7306462A NL 7306462 A NL7306462 A NL 7306462A NL 7306462 A NL7306462 A NL 7306462A
Authority
NL
Netherlands
Application number
NL7306462A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26941978&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL7306462(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of NL7306462A publication Critical patent/NL7306462A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7306462A 1972-05-10 1973-05-09 NL7306462A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/252,030 US4304907A (en) 1972-05-10 1972-05-10 Bicyclo lactone intermediates for prostaglandin analogs
US05/426,058 US4303796A (en) 1972-05-10 1973-12-19 16-Phenoxy prostaglandin F2α analogs

Publications (1)

Publication Number Publication Date
NL7306462A true NL7306462A (fr) 1973-11-13

Family

ID=26941978

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7306462A NL7306462A (fr) 1972-05-10 1973-05-09

Country Status (8)

Country Link
US (8) US4304907A (fr)
AU (1) AU470415B2 (fr)
BE (1) BE799372A (fr)
CH (2) CH585711A5 (fr)
DE (1) DE2322673A1 (fr)
FR (1) FR2184007B1 (fr)
GB (3) GB1409841A (fr)
NL (1) NL7306462A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864387A (en) * 1973-05-21 1975-02-04 Upjohn Co 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs
US4021425A (en) * 1974-12-12 1977-05-03 Imperial Chemical Industries Limited Process for producing enone intermediates
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1538871A (en) * 1975-01-24 1979-01-24 Lepetit Spa Prostaglandins
DE2655004C3 (de) * 1976-12-02 1980-06-19 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von bicyclischen Laktonen
DE3268099D1 (en) * 1982-06-15 1986-02-06 Ibm Method and apparatus for controlling access to a communication network
US4804787A (en) * 1983-12-22 1989-02-14 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4912235A (en) * 1983-12-22 1990-03-27 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy- and 16-substituted phenoxy-prostatrienoic acid derivatives and their stereoisomers
US4600785A (en) * 1983-12-22 1986-07-15 Syntex (U.S.A.) Inc. Processes and intermediates for making 16-phenoxy and 16-substituted phenoxy-prostatrienoic acid derivatives
US4778904A (en) * 1985-09-13 1988-10-18 Syntex (U.S.A.) Inc. Intermediates for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
US4929740A (en) * 1984-10-09 1990-05-29 Syntex (U.S.A.) Inc. Process for making 16-phenoxy- and 16-(substituted phenoxy)-prostatrienoic acid derivatives
US4755531A (en) * 1986-08-11 1988-07-05 Syntex (U.S.A.) Inc. Thiol esters of 4,5-allenyl prostaglandins and use thereof as antigastric secretion agents
CS264861B1 (en) * 1986-12-12 1989-09-12 Kral Josef Agent for cow natality increase
US5296504A (en) * 1988-09-06 1994-03-22 Kabi Pharmacia Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US5321128A (en) * 1988-09-06 1994-06-14 Kabi Pharmacia Ab Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
US6187813B1 (en) 1990-04-10 2001-02-13 Pharmacia & Upjohn Aktiebolag Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
EP1224934A3 (fr) * 1988-09-06 2003-03-26 Pharmacia AB Dérivés de prostaglandines pour le traitement du glucome et de l'hypertension oculaire
JP3097145B2 (ja) * 1991-02-27 2000-10-10 日産化学工業株式会社 コーリーラクトンジオールの光学分割方法
EP0638605B1 (fr) * 1993-08-10 1998-12-09 Shin-Etsu Chemical Co., Ltd. Procédé de préparation d'une résine de polyester modifié par un siloxane et composition durcissable à base de cette résine
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US7851504B2 (en) * 2005-03-16 2010-12-14 Allergan, Inc. Enhanced bimatoprost ophthalmic solution
WO2010102078A1 (fr) 2009-03-04 2010-09-10 Allergan, Inc. Solution ophtalmique améliorée à base de bimatoprost
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US20110293549A1 (en) 2009-02-03 2011-12-01 Athena Cosmetics, Inc. Composition, method and kit for enhancing hair
WO2010108012A1 (fr) * 2009-03-18 2010-09-23 Duke University Compositions et procédés pour améliorer la perméabilité nasale et traiter la vessie neurogène employant des prostaglandines
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
CN102858956B (zh) * 2010-02-25 2015-08-26 Abt控股公司 血管生成的调节
US20110206647A1 (en) * 2010-02-25 2011-08-25 Abt Holding Company Modulation of Angiogenesis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3505386A (en) * 1965-12-29 1970-04-07 Upjohn Co Compounds related to prostaglandins
US3711528A (en) * 1970-04-06 1973-01-16 Upjohn Co Racemic dihydro-pge{11 {11 and related compounds
US3711515A (en) * 1970-11-27 1973-01-16 Upjohn Co Tricyclic lactone alkene or alkenyne
IE37602B1 (en) * 1971-05-11 1977-08-31 Ici Ltd Cyclopentane derivatives
US4024179A (en) * 1972-11-08 1977-05-17 Pfizer Inc. Substituted ω-pentanorprostaglandins

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3864387A (en) * 1973-05-21 1975-02-04 Upjohn Co 5-Oxa phenyl-and phenoxy-substituted prostaglandin F{HD 1{301 {0 {B analogs
US4021425A (en) * 1974-12-12 1977-05-03 Imperial Chemical Industries Limited Process for producing enone intermediates
US4032561A (en) * 1975-05-27 1977-06-28 The Upjohn Company 17-Phenyl-18,19,20-trinor-cis-4,5-didehydro-PGF1.sub.α compounds
US4149006A (en) * 1977-01-24 1979-04-10 G. D. Searle & Co. Prostaglandin derivatives having alkynyl, hydroxy and aryloxy junctions in the 2β side chain

Also Published As

Publication number Publication date
GB1409843A (en) 1975-10-15
DE2322673A1 (de) 1973-11-22
US4303796A (en) 1981-12-01
US4304907A (en) 1981-12-08
US4116988A (en) 1978-09-26
AU5500673A (en) 1974-10-31
US4096178A (en) 1978-06-20
US4096179A (en) 1978-06-20
BE799372A (fr) 1973-11-12
FR2184007A1 (fr) 1973-12-21
FR2184007B1 (fr) 1979-01-12
CH585711A5 (fr) 1977-03-15
US4116989A (en) 1978-09-26
CH585712A5 (fr) 1977-03-15
GB1409842A (en) 1975-10-15
AU470415B2 (en) 1976-03-18
GB1409841A (en) 1975-10-15
US4096335A (en) 1978-06-20
US4087616A (en) 1978-05-02

Similar Documents

Publication Publication Date Title
FR2184007B1 (fr)
FR2174964B1 (fr)
JPS4893778A (fr)
FR2208238A1 (fr)
JPS5222619B2 (fr)
JPS5418521B2 (fr)
JPS499660U (fr)
JPS5345321Y2 (fr)
JPS4923339U (fr)
CS170361B1 (fr)
CS157568B1 (fr)
JPS4880573A (fr)
JPS4972290A (fr)
JPS4987931U (fr)
CH563645A5 (fr)
CH561109A5 (fr)
CH560361A5 (fr)
CH559905A5 (fr)
CH564180A5 (fr)
CH565586A5 (fr)
CH559286A5 (fr)
CH1570573A4 (fr)
CH1477073A4 (fr)
CH1372372A4 (fr)
BG22750A1 (fr)

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed